Kyunghoon Min

Prof. Kyunghoon Min


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MAMaqusood Alam
Maqusood Alam
Ahmed H.E. HassanAhmed H.E. Hassan
Ahmed H.E. Hassan
KLKun Won Lee
Kun Won Lee
MCMin Chang Cho
Min Chang Cho
JYJi Seul Yang
Ji Seul Yang
YLYong Sup Lee
Yong Sup Lee

1 August 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DKDoran Kim
Doran Kim
JBJihae Baek
Jihae Baek
JSJiho Song
Jiho Song
HBHyeyoung Byeon
Hyeyoung Byeon
HMHyeyoung Min
Hyeyoung Min
KMKyunghoon Min
Kyunghoon Min

1 February 2019 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JSJiho Song
Jiho Song
SJSoyeon Jang
Soyeon Jang
JLJung Wuk Lee
Jung Wuk Lee
DJDanbee Jung
Danbee Jung
SLSeul Lee
Seul Lee
KMKyunghoon Min
Kyunghoon Min

22 November 2019 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
DHDong Jin Hong
Dong Jin Hong
SJSeung Hyun Jung
Seung Hyun Jung
JKJisook Kim
Jisook Kim
DJDanbee Jung
Danbee Jung
YAYoung Gil Ahn
Young Gil Ahn
KMKyunghoon Min
Kyunghoon Min
A novel series of thieno[3,2-d]pyrimidine derivatives were synthesised and their inhibitory effects against diacylglycerol acyltransferase 1 (DGAT-1) were assessed. cis-Isomer 17a showed potent and selective inhibitory activity against DGAT-1 in SF9 cells. In addition, 17a had an acceptable pharmacokinetic profile and accumulated mainly in the small intestine and liver. Oral administration of 17a led to a significant reduction in plasma triacylglycerol level during an oral lipid tolerance test (OLTT) in murine and canine models. Taken together, 17a is a high-quality candidate that deserves further investigation.

24 September 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJiho Song
Jiho Song
JYJakyung Yoo
Jakyung Yoo
AKAra Kwon
Ara Kwon
DKDoran Kim
Doran Kim
HNHong Khanh Nguyen
Hong Khanh Nguyen
KMKyunghoon Min
Kyunghoon Min
Antiangiogenic agents have been widely investigated in combination with standard chemotherapy or targeted cancer agents for better management of advanced cancers. Therapeutic agents that concurrently inhibit epidermal growth factor receptor and other angiokinases could be useful alternatives to combination therapies for epidermal growth factor receptor-dependent cancers. Here, we report the synthesis of an indole derivative of pazopanib using a bioisosteric replacement strategy, which was designated MKP101. MKP101 inhibited not only the epidermal growth factor receptor with an IC50 value of 43 nM but also inhibited angiokinases as potently as pazopanib. In addition, MKP101 effectively inhibited vascular endothelial growth factor-induced endothelial proliferation, tube formation, migration of human umbilical vein endothelial cells and proliferation of HCC827, an epidermal growth factor receptor-addicted cancer cell line. A docking model of MKP101 and the kinase domain of the epidermal growth factor receptor was generated to predict its binding mode, and validated by synthesizing and evaluating MKP101 derivatives. Additionally, a study of structure-activity relationships of indolylamino or indolyloxy pyrimidine analogues derived from MKP101 demonstrated that selectivity for epidermal growth factor receptor and other angiokinases, especially vascular endothelial growth factor receptor 2 depends on the position of substituents on pyrimidine and the type of link between pyrimidine and the indole moiety. We believe that this study could provide a basis for developing angiokinase inhibitors having high affinity for the epidermal growth factor receptor, from the pyrimidine scaffold.

1 December 2011 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DCDong Jo Chang
Dong Jo Chang
MJMi Young Jeong
Mi Young Jeong
JSJiho Song
Jiho Song
CJChang Yun Jin
Chang Yun Jin
YSYoung-Ger Suh
Young-Ger Suh
KMKyunghoon Min
Kyunghoon Min